Table of contents

Therapeutics

• Aerobic plus resistance training was more effective than either alone in type 2 diabetes (28 March, 2008) Free
• Review: diet interventions, with or without exercise, promote weight loss more than advice alone (28 March, 2008)
• Review: delayed or immediate prescriptions of antibiotics have similar clinical outcomes in respiratory infections (28 March, 2008)
• Both low-dose and micro-dose 17β-oestradiol reduced hot flushes (28 March, 2008)
• Early treatment with prednisolone, but not acyclovir, was effective in Bell’s palsy (28 March, 2008)
• Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation (28 March, 2008)
• A probiotic drink prevented diarrhoea and Clostridium difficile infection in older patients taking antibiotics (28 March, 2008)
• Review: vitamin D supplementation decreases all-cause mortality in adults and older people (28 March, 2008)
• Daily vitamin C prevented development of complex regional pain syndrome in adults with wrist fractures (28 March, 2008)
• Perindopril plus indapamide reduced death and major macrovascular and microvascular events in type 2 diabetes (28 March, 2008)
• Review: β-blockers for hypertension increase risk of new onset diabetes (28 March, 2008)
• Treatment review by case conferences led to more medication changes than written feedback in older people on polypharmacy (28 March, 2008)
• Combined HRT increased CV events more than placebo but did not differ from oestrogen HRT after menopause (28 March, 2008)
• Review: calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in older people (28 March, 2008)
• A 16-week tai chi programme prevented falls in healthy older adults (28 March, 2008)
• Pharmacogenetic-guided and standard dosing did not differ for out-of-range INRs in patients initiating warfarin therapy (28 March, 2008)
• Review: long-acting inhaled therapies and pulmonary rehabilitation are effective in stable COPD (28 March, 2008)
• Review: corticosteroids plus long-acting β-agonists reduce exacerbations more than long-acting β-agonists alone in COPD (28 March, 2008)